Dr John Herman Bowman, MD | |
824 Waterfront Dr, Lancaster, PA 17602-4122 | |
(717) 392-3144 | |
Not Available |
Full Name | Dr John Herman Bowman |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 824 Waterfront Dr, Lancaster, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477824589 | NPI | - | NPPES |
MD026569L | Other | PA | MEDICAL PHYSICIAN AND SURGEON LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | MD026569L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Herman Bowman, MD 824 Waterfront Dr, Lancaster, PA 17602-4122 Ph: (717) 392-3144 | Dr John Herman Bowman, MD 824 Waterfront Dr, Lancaster, PA 17602-4122 Ph: (717) 392-3144 |
News Archive
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
As people seek healthier dietary regimens they often turn to things labeled "organic." Lurking in the background, however, is an ingredient that may be a hidden source of arsenic-an element known to be both toxic and potentially carcinogenic.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, announces today that it has entered into an agreement with Alcon (a division of Novartis), the global leader in eyecare, for the commercialization of ocriplasmin in all markets outside the U.S.
Screening for atrial fibrillation in 75- and 76-year-olds could reduce the risk of stroke, severe bleeding and death, according to a study at Karolinska Institutet in Sweden that has been published in the journal The Lancet.
A previously unknown autoimmune muscle disease involving sudden onset of debilitating muscle pain and weakness has been identified by researchers at Washington University School of Medicine in St. Louis.
› Verified 1 days ago
John William Sharp Jr., MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1254 Lititz Pike, Lancaster, PA 17601 Phone: 717-397-4724 Fax: 717-397-6687 | |
William M Spitler Iii, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2108 Harrisburg Pike, Ste 100, Lancaster, PA 17601 Phone: 717-544-3900 Fax: 717-544-3910 | |
Dr. Patrick T Tiedeken, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2170 Noll Dr Ste 400, Lancaster, PA 17603 Phone: 717-417-8950 | |
Dr. Justin L Cappiello, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 324 N Duke St, Lancaster, PA 17603 Phone: 717-394-6808 Fax: 717-299-4133 | |
Adam Ryan Thode, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2115 Noll Dr, Lancaster, PA 17603 Phone: 717-393-7980 Fax: 717-509-5079 | |
Dina Y. Gewaily, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2150 Harrisburg Pike, Ste 370, Lancaster, PA 17601 Phone: 717-399-8790 Fax: 717-399-3279 | |
Pierre K Palandjian, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1254 Lititz Pike, Lancaster, PA 17601 Phone: 717-397-4724 Fax: 717-397-6687 |